TM
Tak W. Mak
Director
Tak W. MakDirector
Tak W. Mak insider trades: CASI Pharmaceuticals (CASI) SEC Form 4 filings
Director, CASI Pharmaceuticals 6 Form 4 filings
6
Form 4 filings
last Mar 4, 2016
6
Grants and awards
filings
2
Companies
Companies
Where Tak reports to the SEC
About Tak W. Mak's insider trades
Tak W. Mak is a director at CASI Pharmaceuticals (CASI). Tak has not reported an open-market purchase or sale.
Their filings also include grants and awards (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CASI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.